Insomnia China Prescription Drug Sales Data 2010


August 1, 2011
SKU: DCO6482757
License type:
Countries covered: China

2011 China Prescription Drug Sales Database provides the following information:

1) 2010 national sales of individual therapeutic area
2) 2010 national sales from each of the top manufacturers in each therapeutic area
3) 2010 national sales and market shares for each of the top drugs in each therapeutic area
4) 2010 national sales of the top drugs by each of the competing manufacturers
5) Names, packages, prices and manufacturers of brand and generic drugs in each therapeutic area

Please note: this is delivered as a Excel file.


Additional Information

1. Top 20 Pharmaceutical Companies in China’s Anti-Allergic Drug Market (At least >0.84% of the Chinese anti-allergic drug market)
Chongqing Huabang
India Ranbaxy Labs
Shenzhen Xinlitai
Zhejiang Hangzhou Aoyi Baoling
Beijing Shuanglu
Chengdu Minyi
Chongqing Kailin
Guangdong Zhuhai Lianbang
Hainan Puli
Henan Sanmenxia Sainuo
Hubei Yidu Dongyang
Jiangsu Changzhou No 4 Pharma
Jiangsu Lianhuan
Nanjing Yihua
Schering-Plough China
Shandong Lunan
Shenzhen Haibin
Suzhou Weicai
UCB
Xian-Janssen
2. Top 20 Pharmaceutical Companies in China’s Anti-Asthma Drug Market(At least > 0.53% of the Chinese anti-asthma drug market)
Boehringer Ingelheim
Zhejiang Beisheng
AstraZeneca
GSK
Guangdong Huanqiu
Guangzhou Maite-Xinghua
Guilin Nanyao
Hangzhou MSD China
Heilongjiang Fuhe Huaxing
Draco
Henan Kaifeng Kangnuo
Hengyang Hengsheng
Jiangsu China Medicine and Technology University
Otsuka Pharmaceutical Co Ltd
Qingzhou Yaowang
Sankyo
Shandong Hualu
Shandong Ruiyang
Shanghai Aidifa
Sichuan Chengdu Huayu
Zhejiang Changxing
3. Top 20 Pharmaceutical Companies in China’s Anti-BPH Drug Market(At least > 0.58% of the Chinese anti-BPH drug market)
Changchun Yixin
Madaus AG
Polichem S.A.
Xian Lijun
Zhejiang Hailisheng
Abbott Shanghai
Beijing Saike
Byk Gulden
Hangzhou Sanofi-Synthelabo
Hebei Taiyangshi
Henan Tianfang
Jiangsu Lianhuan
Merck Sharp & Dohme MSD China
Nanjing Meirui
Pfizer Dalian
Shandong Lunan
Tianjin Tong Ren Tang
Yamanouchi (Astellas)
Zhejiang Kangenbei
Zhejiang Xianju
Draco
4. Top 20 Pharmaceutical Companies in China’s Anti-Depressant Drug Market (At least > 0.29% of the Chinese anti-depressant drug market)
Changzhou Siyao
Dr.Willmar Schwabe GmbH & Co
Jiangsu Changzhou Huasheng
Novartis
Taiwan Lotus pharmaceutical Co
Zhejiang Jianfeng
Chengdu Daxinan
Eli Lilly & Co
H.Lundbeck A/S.
Hunan Dongting
N.V. Organon
Pfizer Dalian
Shanghai Zhongxi
Sichuan Zhenzhu
Solvay
Tianjin Smith Kline & French laboratories Ltd
Wuxi Huayu
Wyeth-Whitehall (Suzhou)
Zhejiang Huahai
Zhejiang Jingxin
5. Top 20 Pharmaceutical Companies in China’s Anti-Dermatosis Drug Market (At least > 1.17% of the Chinese anti- dermatosis drug market)
Chongqing Huabang
Novartis
Xian-Janssen
Daiichi Seiyaku
Tianjin Pharmaceutical
Hong Kong Bright Future
Schering-Plough China
Tianjin SmithKline & French Laboratories Ltd.
Shandong Qilu
LEO Pharmaceutical
Laboratories Galderma S.A
Shanghai Likang
Draco
Shanghai Xinyi
Luitpold-Werk, Chemisch-Pharma, Fabrik
Bayer
Jiangsu Jichuan
Teijin Limited
Sichuan Dikang
Zhejiang Hangzhou Yishute
GSK
6. Top 20 Pharmaceutical Companies in China’s Anti-Diabetics Drug Market (At least > 0.57% of the Chinese anti-diabetics drug market)
Bayer
Beijing Liling Hengtai
Beijing Taiyang
Eli Lilly
GlaxoSmithKline
Hangzhou Zhongmei Huadong Pharmaceutical Ltd.
Jiangsu Hangshen
Jiangsu Hengrui
Jiangsu Wangbang BioChem Co
Novartis
Novo Nordisk
Pfizer
sanofi-aventis
Servier (Tianjin)
Shanghai BMS
Taiji Group Chongqing Fuling Pharmaceutics
Takeda
Tonghua Dongbao
Wanhui Shanghe
Yangtze River
Draco
7. Top 20 Pharmaceutical Companies in China’s Anti-Fungal Drug Market(At least > 0.51% of the total China’s anti-fungal drug market)
Shanghai Sunve
Bayer
Chengdu Peite
Chongqing Huabang
Novartis
Tianjin Lisheng
Tianjin Smith Kline & French laboratories
Xian-Janssen
Yangtze River
Zhuhai Yibang
Abbott
Alza Corporation
Chengdu Huashen
Hangzhou Mingsheng
Jiangsu Tianhe Disainuo
MSD
Pfizer
Shandong Qilu
Shanghai Xinxianfeng
Torrent Pharmaceuticals Ltd
8. Top 20 Pharmaceutical Companies in China’s Anti-Hypertension Drug Market (At least > 0.86% of the Chinese anti-hypertension drug market)
Bayer
Pfizer
Novartis
AstraZeneca
MSD
sanofi-aventis
BMS
Beijing Saike
Jilin Tianfeng
Servier
Roche
Merck
Draco
Yangtze River
Boehringer-Ingelheim
Altana Pharma AG
Tanabe
Suzhou Dong Rui Jiangsu Suzhou Dongrui
Jiangsu Nanjing Xingang
Beijing Huasu
Shanghai Xiandai
9. Top 20 Pharmaceutical Companies in China’s Anti-Hyperlipidemics Drug Market (At least > 0.31% of the Chinese anti-hyperlipidemics drug market)
Beijing Baihui
Beijing Wansheng
Ethypharm
Henan Tianfang
Jiangsu Huarui
Laboratories Foumier S.A
Pharmacia & Upjohn (Pfizer)
Shandong Qilu
Yangtze River
Zhejiang Haizheng
Zhejiang Jingxin
Beida Weixin
Beijing Honghui
BMS
Guangzhou Nanxin
MSD
Novartis
Pfizer
Sankyo
Shandong Lunan
Draco
10. Top 20 Pharmaceutical Companies in China’s Anti-Peptic Ulcer Drug Market (At least > 0.95% of the Chinese anti-peptic ulcer drug market)
AstraZeneca
Altana Pharma AG
Bayer
Changzhou Siyao
Guangdong Lizhu
Guangdong Tuobin
Hainan Huanglong
Hangzhou Zhongmei Huadong
Jiangsu Haoshen
Seiko Eiyo Yakuhin
Shandong Luye
Shandong Lunan
Shanghai Xinyi
Shenyang Dongyu
Sichuan Dikang
Weicai
Xian-Janssen
Yamanouchi
Yangtze River
Yangzhou Aosaikang
11. Top 20 Pharmaceutical Companies in China’s Sedative Hypnotic Drug Market (At least > 0.96% of the Chinese sedative hypnotic drug market)
AstraZeneca
Atlantic Laboratories Corp Ltd
Changzhou Huasheng
Chengdu Daxinan
Eli Lilly & Co
Guizhou Shengqi
Guizhou Yikang
H.Lundbeck A/S
Hangzhou Sanofi-Synthelabo
Hunan Dongting
Kunming Zhiyao
Roche
Shandong Qilu
Draco
Shanghai Jiufu
Suzhou No.1
Wandashan
Wusulijiang Pharma
Xian-Janssen
Xuzhou Enhua
Zhejiang Yongning
12. Top 20 Pharmaceutical Companies in China’s Anti Senile Dementia Drug Market (At least > 0.96% of the Chinese anti senile dementia drug market)
Harbin Sanlian
Beijing Shuanghe
Guangdong Shixin
Guizhou Yibai
Hainan Tongyong Sanyang
Heilongjiang Feixia
Heilongjiang Zhenbaodao
Henan Lingrui
Kunming Longjin
Nanjing Xiansheng Dongyuan
Shandong Qilu
Shanghai Xinxianfeng
Shanxi Pude
Shanxi Wanrong
Shijiazhuang Shenwei
TRB Pharma S.A.
Willmar Schwabe
Yangtze River
Yunnan Shengwugu Dengzhanhua (Herba Erigerontis)
Hunan Jianlang
Draco
13. Top 20 Pharmaceutical Companies in China’s Anti-Thrombotic Drug Market (At least > 0.85% of the Chinese anti-thrombotic drug market)
Anhui Zhaoke
Beijing Baiao
Beijing Bituoxi
Boehringer Ingelheim
Changchun Haobang
Changchun Jinyou
Dalian Meiluo
Dandong Yichuang
GSK
Guangdong Tianpu
Hainan Bikai
Hainan Tongyong Tongmeng
Otsuka
Pfizer
sanofi-aventis
Shenyang Jishi
Shenzhen Xinlitai
Tianjin Hongri
Tianjin Shengwu
Wuhan Yuanda
14. Top 20 Pharmaceutical Companies in China’s Blood Product Drug Market (At least > 1.21 % of the Chinese blood product drug market)
Guangzhou Baiyunshan Qiaoguang
Anhui Fengyuan
Aventis Behring
B. Braun Melsungen
Baxter
Beijing Shuanghe
Chengdu Rongsheng
Chongqing Xinan
Fresenius Kabi
Green Cross
Harbin Sanlian
Hualan Shengwu
Jiangsu Huarui
Draco
Jinzhou Aohong
Otsuka
Shanghai RAAS
Sichuan Kelun
Sichuan Yuanda Shuyang
Tianjin Tianan
Wuxi Nutricia
15. Top 20 Pharmaceutical Companies in China’s Ophthalmological Market(At least > 0.88% of the Chinese Ophthalmological drug market)
Santen Pharmaceutical Co
Senju Pharmaceutical
Shanghai Xinyi
Alcon
Allergan U.S.A.(US)
Beijing Zizhu
Ferring Pharmaceuticals
Guangdong Zhuhai Lianbang
Guangdong Zhuhai Yisheng
Hubei Dongsheng
Laboratories Leurquin Mediolanum SA
Lizhu Group
Novartis
Otsuka Pharmaceutical Co
Pharmacia Upjohn (Pfizer)
Shandong Zhenda Furuida
Shenyang Xinqi
Shenzhen Huashengyuan
Sichuan Shenghe
Wuhan Wujing
16. Top 20 Pharmaceutical Companies in China’s Macrolide Antibiotics Drug Market (At least > 1.04% of the Chinese macrolide antibiotics drug market)
Abbott
Beijing Taiyang
Dongbei Zhiyao
Guangdong Lizhu
Draco
Hainan Sida
Harbin Pharmaceutical Group
Jiangsu Hengrui
Jiangsu Jichuan
Jiangsu Jinsili
Pfizer
Pliva
POLFA
Shandong Qilu
Shenzhen Wanhe
Shijiangzhuang Pharma
Sichuan Kelun
Xian Lijun
Yangtze River
Zhejiang Jianfeng
Zhejiang Zhongyi
17. Top 20 Pharmaceutical Companies in China’s Anti-Cancer Drug Market(At least > 1.3 % of the Chinese anti-cancer drug market)
Jiangsu Hansen Pharmaceutical Co., Ltd.(Hansen Pharma)
Jiangsu Hengrui Medicine Co., Ltd
Novartis
Pfizer
Roche
sanofi-aventis
Sichuan Diao Jiuhong Group Pharmaceutical Co
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Guizhou Baiqiang Pharmaceutical Co., Ltd.
Hainan Zhonghe Pharmaceutical Co., Ltd
JINLING PHARMACEUTICAL CO.,LTD
LIVZON Pharmaceutical Group Inc.
Nanjing Kanghai Pharmaceutical Co., Ltd
Nanjing Sike Pharmaceutical Co. Ltd
Qilu Pharmaceutical Co., Ltd
SciClone Pharmaceuticals Italy S.R.l.
Shenzhen Wanle Pharmaceutical Co,.Ltd
Draco
Zhejiang Hisun Pharmaceutical Co,.Ltd
18. Top 20 Pharmaceutical Companies in China’s Rheumatoid Arthritis Drug Market (At least > 1.08% of the Chinese rheumatoid arthritis drug market)
Beijing Taide
Boehringer Ingelheim
Fujian Huitian
German Fujisawa Deutschland GmbH
Guilin Tianhe
Harbin Yuheng
Heilongjiang Dilong
Heilongjiang Jiangshi
Hong Kong Bright Future Pharmaceuticals Factory
Johnson & Johnson
Lingnan Pharma Hong Kong
Novartis
Nycomed Austria GmbH
Pfizer
Rotta Research Laboratorium S.P.A.
Shanxi Zhongyuanwei
Suzhou Changzhen Xinkai
Tianjin SmithKline & French Laboratories Ltd
Tibet Qizheng Zhangyao
Zhejiang Haizheng

More Pricing reports by Draco Healthcare Consulting LLC

Senile Dementia China Prescription Drug Sales Data 2010 by Draco Healthcare Consulting LLC
2011 China Prescription Drug Sales Database provides the following information: 1) 2010 national sales of individual therapeutic area 2) 2010 national sales ...
See all reports like this >>

More China Pricing reports

China: Market Access Tracker by Decision Resources
Decision Resources’ Market Access Tracker service for the Asia Pacific region explains the challenges and opportunities to gaining and maintaining favorable market access terms in ...
Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures by GBI Research
Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare ExpendituresSummaryGBI Research, the leading business intelligence provider, has ...
The Pharmaceutical Market: China by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Healthcare, Regulatory and Reimbursement Landscape - China by GlobalData
Healthcare, Regulatory and Reimbursement Landscape - ChinaSummaryGlobalData, Industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - China”. The report is ...
See all reports like this >>

More China reports

Eyewear in Hong Kong, China by Euromonitor International
Chinese mainland tourists with a preference for international spectacle brands are the key driver for high volume and value growth. Minimum wage ordinance passed in ...
D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>